Showing posts with label Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension. Show all posts
Showing posts with label Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension. Show all posts
Wednesday, April 24, 2019

FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension

›
In continuation of my update on   latanoprost   Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic phar...